This highlights a key role for CEACAM1-dependent insulin clearance pathways in maintaining insulin sensitivity and limiting hepatic steatosis by promoting hepatic insulin clearance and mediating the anti-lipogenic effect of acutely released insulin in hepatocytes. Here, INS is linked to fatty liver disease.